Amarin Corp Plcuk (AMRN) Capital Expenditures (2010 - 2020)

Amarin Corp Plcuk (AMRN) posted quarterly Capital Expenditures of $1000.0 for Q3 2020, down 99.92% YoY from $1.3 million in Q4 2019, and down 99.6% sequentially from $251000.0 in Q1 2020.

Amarin Corp Plcuk (AMRN) Capital Expenditures (2010 - 2020) Analysis & Trends

Amarin Corp Plcuk has disclosed Capital Expenditures across 10 years of filings, most recently posting $1000.0 for Q3 2020.

  • In Q3 2020, Capital Expenditures fell 99.92% year-over-year to $1000.0; the TTM figure through Dec 2020 stood at $252000.0 (down 85.02% YoY), while the FY2020 annual figure was $252000.0, down 89.83% from the prior year.
  • Capital Expenditures retreated to $1000.0 in Q3 2020, from $251000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for AMRN reached as high as $1.3 million in Q3 2019 and fell as low as $1000.0 in Q3 2020.
  • The 5-year median for Capital Expenditures is $21000.0 (2016), against an average of $281000.0.
  • Annual changes were most pronounced in 2019 — Capital Expenditures soared 7180.0% — and 2020, when it slumped 99.92%.
  • A 5-year view of Capital Expenditures shows it stood at $21000.0 in 2016, then sank by 42.86% to $12000.0 in 2017, then plunged by 58.33% to $5000.0 in 2018, then soared by 7180.0% to $364000.0 in 2019, then sank by 99.73% to $1000.0 in 2020.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $1000.0, $251000.0, and $364000.0 for Q3 2020, Q1 2020, and Q4 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 2.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 265.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -547.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 991.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 712.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 117.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 436.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -346.00 Mn
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 1,000.00
Sep 30, 2020 1,000.00
Mar 31, 2020 251,000.00
Mar 31, 2020 251,000.00
Dec 31, 2019 364,000.00
Dec 31, 2019 364,000.00
Sep 30, 2019 1.31 Mn
Sep 30, 2019 1.31 Mn
Dec 31, 2018 5,000.00
Dec 31, 2018 5,000.00
Mar 31, 2017 12,000.00
Mar 31, 2017 12,000.00
Mar 31, 2016 21,000.00
Mar 31, 2016 21,000.00
Dec 31, 2015 18,000.00
Dec 31, 2015 18,000.00
Mar 31, 2013 14,000.00
Mar 31, 2013 14,000.00
Dec 31, 2012 72,000.00
Dec 31, 2012 72,000.00